Broadleaf came into this earnings print with the stock drifting, down around 5% over the past week and roughly flat over the past month, despite carrying a premium P/E of 42.8x against software peers. The headline today is earnings quality. Net profit margin over the last year sat at 8.4% versus 4% a year earlier, and reported earnings over that period were very large relative to the prior year. The share price at ¥431 now sits only slightly below a discounted cash flow value of ¥447.68, so investors are weighing how much of this profitability story is already in the price.
Is Broadleaf’s 42.8x P/E a fair price for the recent margin and EPS improvement, or is the stock already fully pricing in the good news? Compare the current share price against our valuation analysis for Broadleaf.
Prefer clean charts instead of another wall of earnings tables and ratios? See Broadleaf’s full financial picture with a visual breakdown of its recent profitability trend in the company report for Broadleaf.
For investors leaning positive on Broadleaf, the latest figures broadly back the idea of a healthier core business. Revenue in Q2 2026 is slightly higher than a year earlier, which is helpful for a software and services model that often depends on steady client activity. The bigger swing is on profitability. Net income excluding extra items has more than doubled and the trailing 12 month net margin has moved from 4% to 8.4%. That pairing suggests the mobility focused software platform is converting its revenue base into earnings more efficiently.
On the cautious side, the share price tells a different story. Broadleaf is down roughly 5% over 7 days and around 9% over 3 months to ¥431 as of 14 August 2026. That pullback signals investors are not fully embracing the earnings jump yet. Some may question how durable the higher margin is or worry about mobility sector exposure. The tension between improving reported profitability and a weaker share price keeps execution risk and end market dependence very much in focus.
With Broadleaf trading on a richer P/E and recent earnings looking stronger on paper, the real question is whether the balance sheet and cash flows quietly tell a different story. Check the full financial health analysis of Broadleaf stockIf Broadleaf’s richer P/E and recent margin improvement have your attention, register for free with Simply Wall St and add it to your Watchlist to track the share price against fair value and watch for a more attractive entry point. After you own Broadleaf or any other stock, use the Portfolio Command Center to cut through day to day noise and focus on the updates that matter most to your holdings. For a broader view on what other investors are seeing, join the Community and compare your thesis with real world sentiment and ideas. By spotting hidden catalysts and risks early, you give yourself a way to stay informed about the market and act with confidence.
Markets move quickly and the next breakout often starts flying before most investors notice. Scan these fresh stock ideas while the data still matters and consider them while they are still timely.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com